Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Neumann Insider Profile
4 Followers
Mark Neumann, EVP & CCO at Intra-Cellular Therapies, holds 29.70K shares in Intra-Cellular Therapies (Ticker: ITCI).
Mark Neumann Intra-Cellular Therapies (ITCI)EVP & CCO
Intra-Cellular Therapies (ITCI)
EVP & CCO
Ranked #82,957 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-36.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & CCO
Roles that Mark Neumann holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Neumann
Mark Neumann's Trading History
List of latest transactions for each holding click on a transaction to see Mark Neumann's performance on stock
You May Also Like
Mark Neumann insider profile FAQ
What is the percentage of profitable transactions made by Mark Neumann?
The percentage of profitable transactions made by Mark Neumann is 0%.
What is the average return per transaction made by Mark Neumann?
The average return per transaction made by Mark Neumann is -36.90%.
What stocks does Mark Neumann hold?
Mark Neumann holds: ITCI stocks.
What was Mark Neumann’s latest transaction?
Mark Neumann latest transaction was an Uninformative Buy of $690.36K.
What was Mark Neumann's most profitable transaction?
Mark Neumann’s most profitable transaction was an Informative Sell of ITCI stock on August 20, 2024. The return on the trade was -18.50%.
What is Mark Neumann's role in Intra-Cellular Therapies?
Mark Neumann's role in Intra-Cellular Therapies is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.